ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biomacromolecule CDMO Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-38A15973
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biomacromolecule CDMO Market Research Report 2023
BUY CHAPTERS

Global Biomacromolecule CDMO Market Research Report 2025

Code: QYRE-Auto-38A15973
Report
May 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Lonza
WuXi Biologics (Cayman) Inc.
Samsung Biologics
Rentschler Biopharma
Baxter BioPharma Solutions
Cytovance Biologics
AGC Biologics
Abzena
Emergent Biosolutions
ProBioGen
Goodwin Biotechnology
KBI Biopharma
Asymchem Laboratories (Tianjin) Co.,Ltd.
Shanghai Chempartner Lifescience Co., Ltd.
Genscript Biotech
Merck BioReliance
Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd.
Beijing Joinn Biologics Co., Ltd.
Thermo Fisher Scientific
Catalent

Biomacromolecule CDMO Market

The global market for Biomacromolecule CDMO was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The macromolecule CDMO industry refers to drugs that rely on cell biosynthesis, usually with a molecular weight greater than 1,000. Macromolecule CDMO mainly focuses on biopharmaceuticals, and the intermediates are relatively unified, mainly including some raw materials, protein and antibody preparation, stable cell lines and process development, and the production and research and development of biological preparations.
North American market for Biomacromolecule CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Biomacromolecule CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Biomacromolecule CDMO in Drug Development is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Biomacromolecule CDMO include Lonza, Wuxi Biologics (Cayman) Inc., Catalent, Thermo Fisher Scientific, Samsung Biologics, Rentschler Biopharma, Baxter Biopharma Solutions, Merck BioReliance, Cytovance Biologics, AGC Biologics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biomacromolecule CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomacromolecule CDMO.
The Biomacromolecule CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biomacromolecule CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biomacromolecule CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Biomacromolecule CDMO Market Report

Report Metric Details
Report Name Biomacromolecule CDMO Market
Segment by Type
Segment by Application
  • Drug Development
  • Vaccine Production
  • Technology Transfer
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Lonza, Wuxi Biologics (Cayman) Inc., Catalent, Thermo Fisher Scientific, Samsung Biologics, Rentschler Biopharma, Baxter Biopharma Solutions, Merck BioReliance, Cytovance Biologics, AGC Biologics, Abzena, Emergent BioSolutions, ProBioGen, Goodwin Biotechnology, KBI Biopharma, Asymchem Laboratories (Tianjin) Co., Ltd., Shanghai Chempartner Lifescience Co., Ltd., Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd., Genscript Biotech, Beijing Joinn Biologics Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Biomacromolecule CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Biomacromolecule CDMO Market report?

Ans: The main players in the Biomacromolecule CDMO Market are Lonza, Wuxi Biologics (Cayman) Inc., Catalent, Thermo Fisher Scientific, Samsung Biologics, Rentschler Biopharma, Baxter Biopharma Solutions, Merck BioReliance, Cytovance Biologics, AGC Biologics, Abzena, Emergent BioSolutions, ProBioGen, Goodwin Biotechnology, KBI Biopharma, Asymchem Laboratories (Tianjin) Co., Ltd., Shanghai Chempartner Lifescience Co., Ltd., Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd., Genscript Biotech, Beijing Joinn Biologics Co., Ltd.

What are the Application segmentation covered in the Biomacromolecule CDMO Market report?

Ans: The Applications covered in the Biomacromolecule CDMO Market report are Drug Development, Vaccine Production, Technology Transfer, Others

What are the Type segmentation covered in the Biomacromolecule CDMO Market report?

Ans: The Types covered in the Biomacromolecule CDMO Market report are Biologics CDMO, Viral Vaccine Production CDMO, Analyze and Test CDMOs, Others

Recommended Reports

CDMO Market Overview

Drug CDMO Segments

CDMO Service Applications

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biomacromolecule CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Biologics CDMO
1.2.3 Viral Vaccine Production CDMO
1.2.4 Analyze and Test CDMOs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Biomacromolecule CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Development
1.3.3 Vaccine Production
1.3.4 Technology Transfer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biomacromolecule CDMO Market Perspective (2020-2031)
2.2 Global Biomacromolecule CDMO Growth Trends by Region
2.2.1 Global Biomacromolecule CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biomacromolecule CDMO Historic Market Size by Region (2020-2025)
2.2.3 Biomacromolecule CDMO Forecasted Market Size by Region (2026-2031)
2.3 Biomacromolecule CDMO Market Dynamics
2.3.1 Biomacromolecule CDMO Industry Trends
2.3.2 Biomacromolecule CDMO Market Drivers
2.3.3 Biomacromolecule CDMO Market Challenges
2.3.4 Biomacromolecule CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biomacromolecule CDMO Players by Revenue
3.1.1 Global Top Biomacromolecule CDMO Players by Revenue (2020-2025)
3.1.2 Global Biomacromolecule CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Biomacromolecule CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biomacromolecule CDMO Revenue
3.4 Global Biomacromolecule CDMO Market Concentration Ratio
3.4.1 Global Biomacromolecule CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biomacromolecule CDMO Revenue in 2024
3.5 Global Key Players of Biomacromolecule CDMO Head office and Area Served
3.6 Global Key Players of Biomacromolecule CDMO, Product and Application
3.7 Global Key Players of Biomacromolecule CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biomacromolecule CDMO Breakdown Data by Type
4.1 Global Biomacromolecule CDMO Historic Market Size by Type (2020-2025)
4.2 Global Biomacromolecule CDMO Forecasted Market Size by Type (2026-2031)
5 Biomacromolecule CDMO Breakdown Data by Application
5.1 Global Biomacromolecule CDMO Historic Market Size by Application (2020-2025)
5.2 Global Biomacromolecule CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biomacromolecule CDMO Market Size (2020-2031)
6.2 North America Biomacromolecule CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biomacromolecule CDMO Market Size by Country (2020-2025)
6.4 North America Biomacromolecule CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biomacromolecule CDMO Market Size (2020-2031)
7.2 Europe Biomacromolecule CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biomacromolecule CDMO Market Size by Country (2020-2025)
7.4 Europe Biomacromolecule CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biomacromolecule CDMO Market Size (2020-2031)
8.2 Asia-Pacific Biomacromolecule CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biomacromolecule CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Biomacromolecule CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biomacromolecule CDMO Market Size (2020-2031)
9.2 Latin America Biomacromolecule CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biomacromolecule CDMO Market Size by Country (2020-2025)
9.4 Latin America Biomacromolecule CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biomacromolecule CDMO Market Size (2020-2031)
10.2 Middle East & Africa Biomacromolecule CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biomacromolecule CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Biomacromolecule CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Biomacromolecule CDMO Introduction
11.1.4 Lonza Revenue in Biomacromolecule CDMO Business (2020-2025)
11.1.5 Lonza Recent Development
11.2 Wuxi Biologics (Cayman) Inc.
11.2.1 Wuxi Biologics (Cayman) Inc. Company Details
11.2.2 Wuxi Biologics (Cayman) Inc. Business Overview
11.2.3 Wuxi Biologics (Cayman) Inc. Biomacromolecule CDMO Introduction
11.2.4 Wuxi Biologics (Cayman) Inc. Revenue in Biomacromolecule CDMO Business (2020-2025)
11.2.5 Wuxi Biologics (Cayman) Inc. Recent Development
11.3 Catalent
11.3.1 Catalent Company Details
11.3.2 Catalent Business Overview
11.3.3 Catalent Biomacromolecule CDMO Introduction
11.3.4 Catalent Revenue in Biomacromolecule CDMO Business (2020-2025)
11.3.5 Catalent Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Biomacromolecule CDMO Introduction
11.4.4 Thermo Fisher Scientific Revenue in Biomacromolecule CDMO Business (2020-2025)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Samsung Biologics
11.5.1 Samsung Biologics Company Details
11.5.2 Samsung Biologics Business Overview
11.5.3 Samsung Biologics Biomacromolecule CDMO Introduction
11.5.4 Samsung Biologics Revenue in Biomacromolecule CDMO Business (2020-2025)
11.5.5 Samsung Biologics Recent Development
11.6 Rentschler Biopharma
11.6.1 Rentschler Biopharma Company Details
11.6.2 Rentschler Biopharma Business Overview
11.6.3 Rentschler Biopharma Biomacromolecule CDMO Introduction
11.6.4 Rentschler Biopharma Revenue in Biomacromolecule CDMO Business (2020-2025)
11.6.5 Rentschler Biopharma Recent Development
11.7 Baxter Biopharma Solutions
11.7.1 Baxter Biopharma Solutions Company Details
11.7.2 Baxter Biopharma Solutions Business Overview
11.7.3 Baxter Biopharma Solutions Biomacromolecule CDMO Introduction
11.7.4 Baxter Biopharma Solutions Revenue in Biomacromolecule CDMO Business (2020-2025)
11.7.5 Baxter Biopharma Solutions Recent Development
11.8 Merck BioReliance
11.8.1 Merck BioReliance Company Details
11.8.2 Merck BioReliance Business Overview
11.8.3 Merck BioReliance Biomacromolecule CDMO Introduction
11.8.4 Merck BioReliance Revenue in Biomacromolecule CDMO Business (2020-2025)
11.8.5 Merck BioReliance Recent Development
11.9 Cytovance Biologics
11.9.1 Cytovance Biologics Company Details
11.9.2 Cytovance Biologics Business Overview
11.9.3 Cytovance Biologics Biomacromolecule CDMO Introduction
11.9.4 Cytovance Biologics Revenue in Biomacromolecule CDMO Business (2020-2025)
11.9.5 Cytovance Biologics Recent Development
11.10 AGC Biologics
11.10.1 AGC Biologics Company Details
11.10.2 AGC Biologics Business Overview
11.10.3 AGC Biologics Biomacromolecule CDMO Introduction
11.10.4 AGC Biologics Revenue in Biomacromolecule CDMO Business (2020-2025)
11.10.5 AGC Biologics Recent Development
11.11 Abzena
11.11.1 Abzena Company Details
11.11.2 Abzena Business Overview
11.11.3 Abzena Biomacromolecule CDMO Introduction
11.11.4 Abzena Revenue in Biomacromolecule CDMO Business (2020-2025)
11.11.5 Abzena Recent Development
11.12 Emergent BioSolutions
11.12.1 Emergent BioSolutions Company Details
11.12.2 Emergent BioSolutions Business Overview
11.12.3 Emergent BioSolutions Biomacromolecule CDMO Introduction
11.12.4 Emergent BioSolutions Revenue in Biomacromolecule CDMO Business (2020-2025)
11.12.5 Emergent BioSolutions Recent Development
11.13 ProBioGen
11.13.1 ProBioGen Company Details
11.13.2 ProBioGen Business Overview
11.13.3 ProBioGen Biomacromolecule CDMO Introduction
11.13.4 ProBioGen Revenue in Biomacromolecule CDMO Business (2020-2025)
11.13.5 ProBioGen Recent Development
11.14 Goodwin Biotechnology
11.14.1 Goodwin Biotechnology Company Details
11.14.2 Goodwin Biotechnology Business Overview
11.14.3 Goodwin Biotechnology Biomacromolecule CDMO Introduction
11.14.4 Goodwin Biotechnology Revenue in Biomacromolecule CDMO Business (2020-2025)
11.14.5 Goodwin Biotechnology Recent Development
11.15 KBI Biopharma
11.15.1 KBI Biopharma Company Details
11.15.2 KBI Biopharma Business Overview
11.15.3 KBI Biopharma Biomacromolecule CDMO Introduction
11.15.4 KBI Biopharma Revenue in Biomacromolecule CDMO Business (2020-2025)
11.15.5 KBI Biopharma Recent Development
11.16 Asymchem Laboratories (Tianjin) Co., Ltd.
11.16.1 Asymchem Laboratories (Tianjin) Co., Ltd. Company Details
11.16.2 Asymchem Laboratories (Tianjin) Co., Ltd. Business Overview
11.16.3 Asymchem Laboratories (Tianjin) Co., Ltd. Biomacromolecule CDMO Introduction
11.16.4 Asymchem Laboratories (Tianjin) Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025)
11.16.5 Asymchem Laboratories (Tianjin) Co., Ltd. Recent Development
11.17 Shanghai Chempartner Lifescience Co., Ltd.
11.17.1 Shanghai Chempartner Lifescience Co., Ltd. Company Details
11.17.2 Shanghai Chempartner Lifescience Co., Ltd. Business Overview
11.17.3 Shanghai Chempartner Lifescience Co., Ltd. Biomacromolecule CDMO Introduction
11.17.4 Shanghai Chempartner Lifescience Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025)
11.17.5 Shanghai Chempartner Lifescience Co., Ltd. Recent Development
11.18 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd.
11.18.1 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Company Details
11.18.2 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Business Overview
11.18.3 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Biomacromolecule CDMO Introduction
11.18.4 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025)
11.18.5 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Recent Development
11.19 Genscript Biotech
11.19.1 Genscript Biotech Company Details
11.19.2 Genscript Biotech Business Overview
11.19.3 Genscript Biotech Biomacromolecule CDMO Introduction
11.19.4 Genscript Biotech Revenue in Biomacromolecule CDMO Business (2020-2025)
11.19.5 Genscript Biotech Recent Development
11.20 Beijing Joinn Biologics Co., Ltd.
11.20.1 Beijing Joinn Biologics Co., Ltd. Company Details
11.20.2 Beijing Joinn Biologics Co., Ltd. Business Overview
11.20.3 Beijing Joinn Biologics Co., Ltd. Biomacromolecule CDMO Introduction
11.20.4 Beijing Joinn Biologics Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025)
11.20.5 Beijing Joinn Biologics Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Lonza
WuXi Biologics (Cayman) Inc.
Samsung Biologics
Rentschler Biopharma
Baxter BioPharma Solutions
Cytovance Biologics
AGC Biologics
Abzena
Emergent Biosolutions
ProBioGen
Goodwin Biotechnology
KBI Biopharma
Asymchem Laboratories (Tianjin) Co.,Ltd.
Shanghai Chempartner Lifescience Co., Ltd.
Genscript Biotech
Merck BioReliance
Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd.
Beijing Joinn Biologics Co., Ltd.
Thermo Fisher Scientific
Catalent
List of Tables
 Table 1. Global Biomacromolecule CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Biologics CDMO
 Table 3. Key Players of Viral Vaccine Production CDMO
 Table 4. Key Players of Analyze and Test CDMOs
 Table 5. Key Players of Others
 Table 6. Global Biomacromolecule CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Biomacromolecule CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Biomacromolecule CDMO Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Biomacromolecule CDMO Market Share by Region (2020-2025)
 Table 10. Global Biomacromolecule CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Biomacromolecule CDMO Market Share by Region (2026-2031)
 Table 12. Biomacromolecule CDMO Market Trends
 Table 13. Biomacromolecule CDMO Market Drivers
 Table 14. Biomacromolecule CDMO Market Challenges
 Table 15. Biomacromolecule CDMO Market Restraints
 Table 16. Global Biomacromolecule CDMO Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Biomacromolecule CDMO Market Share by Players (2020-2025)
 Table 18. Global Top Biomacromolecule CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomacromolecule CDMO as of 2024)
 Table 19. Ranking of Global Top Biomacromolecule CDMO Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Biomacromolecule CDMO Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Biomacromolecule CDMO, Headquarters and Area Served
 Table 22. Global Key Players of Biomacromolecule CDMO, Product and Application
 Table 23. Global Key Players of Biomacromolecule CDMO, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Biomacromolecule CDMO Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Biomacromolecule CDMO Revenue Market Share by Type (2020-2025)
 Table 27. Global Biomacromolecule CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Biomacromolecule CDMO Revenue Market Share by Type (2026-2031)
 Table 29. Global Biomacromolecule CDMO Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Biomacromolecule CDMO Revenue Market Share by Application (2020-2025)
 Table 31. Global Biomacromolecule CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Biomacromolecule CDMO Revenue Market Share by Application (2026-2031)
 Table 33. North America Biomacromolecule CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Biomacromolecule CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Biomacromolecule CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Biomacromolecule CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Biomacromolecule CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Biomacromolecule CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Biomacromolecule CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Biomacromolecule CDMO Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Biomacromolecule CDMO Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Biomacromolecule CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Biomacromolecule CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Biomacromolecule CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Biomacromolecule CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Biomacromolecule CDMO Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Biomacromolecule CDMO Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Lonza Company Details
 Table 49. Lonza Business Overview
 Table 50. Lonza Biomacromolecule CDMO Product
 Table 51. Lonza Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
 Table 52. Lonza Recent Development
 Table 53. Wuxi Biologics (Cayman) Inc. Company Details
 Table 54. Wuxi Biologics (Cayman) Inc. Business Overview
 Table 55. Wuxi Biologics (Cayman) Inc. Biomacromolecule CDMO Product
 Table 56. Wuxi Biologics (Cayman) Inc. Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
 Table 57. Wuxi Biologics (Cayman) Inc. Recent Development
 Table 58. Catalent Company Details
 Table 59. Catalent Business Overview
 Table 60. Catalent Biomacromolecule CDMO Product
 Table 61. Catalent Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
 Table 62. Catalent Recent Development
 Table 63. Thermo Fisher Scientific Company Details
 Table 64. Thermo Fisher Scientific Business Overview
 Table 65. Thermo Fisher Scientific Biomacromolecule CDMO Product
 Table 66. Thermo Fisher Scientific Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
 Table 67. Thermo Fisher Scientific Recent Development
 Table 68. Samsung Biologics Company Details
 Table 69. Samsung Biologics Business Overview
 Table 70. Samsung Biologics Biomacromolecule CDMO Product
 Table 71. Samsung Biologics Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
 Table 72. Samsung Biologics Recent Development
 Table 73. Rentschler Biopharma Company Details
 Table 74. Rentschler Biopharma Business Overview
 Table 75. Rentschler Biopharma Biomacromolecule CDMO Product
 Table 76. Rentschler Biopharma Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
 Table 77. Rentschler Biopharma Recent Development
 Table 78. Baxter Biopharma Solutions Company Details
 Table 79. Baxter Biopharma Solutions Business Overview
 Table 80. Baxter Biopharma Solutions Biomacromolecule CDMO Product
 Table 81. Baxter Biopharma Solutions Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
 Table 82. Baxter Biopharma Solutions Recent Development
 Table 83. Merck BioReliance Company Details
 Table 84. Merck BioReliance Business Overview
 Table 85. Merck BioReliance Biomacromolecule CDMO Product
 Table 86. Merck BioReliance Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
 Table 87. Merck BioReliance Recent Development
 Table 88. Cytovance Biologics Company Details
 Table 89. Cytovance Biologics Business Overview
 Table 90. Cytovance Biologics Biomacromolecule CDMO Product
 Table 91. Cytovance Biologics Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
 Table 92. Cytovance Biologics Recent Development
 Table 93. AGC Biologics Company Details
 Table 94. AGC Biologics Business Overview
 Table 95. AGC Biologics Biomacromolecule CDMO Product
 Table 96. AGC Biologics Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
 Table 97. AGC Biologics Recent Development
 Table 98. Abzena Company Details
 Table 99. Abzena Business Overview
 Table 100. Abzena Biomacromolecule CDMO Product
 Table 101. Abzena Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
 Table 102. Abzena Recent Development
 Table 103. Emergent BioSolutions Company Details
 Table 104. Emergent BioSolutions Business Overview
 Table 105. Emergent BioSolutions Biomacromolecule CDMO Product
 Table 106. Emergent BioSolutions Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
 Table 107. Emergent BioSolutions Recent Development
 Table 108. ProBioGen Company Details
 Table 109. ProBioGen Business Overview
 Table 110. ProBioGen Biomacromolecule CDMO Product
 Table 111. ProBioGen Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
 Table 112. ProBioGen Recent Development
 Table 113. Goodwin Biotechnology Company Details
 Table 114. Goodwin Biotechnology Business Overview
 Table 115. Goodwin Biotechnology Biomacromolecule CDMO Product
 Table 116. Goodwin Biotechnology Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
 Table 117. Goodwin Biotechnology Recent Development
 Table 118. KBI Biopharma Company Details
 Table 119. KBI Biopharma Business Overview
 Table 120. KBI Biopharma Biomacromolecule CDMO Product
 Table 121. KBI Biopharma Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
 Table 122. KBI Biopharma Recent Development
 Table 123. Asymchem Laboratories (Tianjin) Co., Ltd. Company Details
 Table 124. Asymchem Laboratories (Tianjin) Co., Ltd. Business Overview
 Table 125. Asymchem Laboratories (Tianjin) Co., Ltd. Biomacromolecule CDMO Product
 Table 126. Asymchem Laboratories (Tianjin) Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
 Table 127. Asymchem Laboratories (Tianjin) Co., Ltd. Recent Development
 Table 128. Shanghai Chempartner Lifescience Co., Ltd. Company Details
 Table 129. Shanghai Chempartner Lifescience Co., Ltd. Business Overview
 Table 130. Shanghai Chempartner Lifescience Co., Ltd. Biomacromolecule CDMO Product
 Table 131. Shanghai Chempartner Lifescience Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
 Table 132. Shanghai Chempartner Lifescience Co., Ltd. Recent Development
 Table 133. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Company Details
 Table 134. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Business Overview
 Table 135. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Biomacromolecule CDMO Product
 Table 136. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
 Table 137. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Recent Development
 Table 138. Genscript Biotech Company Details
 Table 139. Genscript Biotech Business Overview
 Table 140. Genscript Biotech Biomacromolecule CDMO Product
 Table 141. Genscript Biotech Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
 Table 142. Genscript Biotech Recent Development
 Table 143. Beijing Joinn Biologics Co., Ltd. Company Details
 Table 144. Beijing Joinn Biologics Co., Ltd. Business Overview
 Table 145. Beijing Joinn Biologics Co., Ltd. Biomacromolecule CDMO Product
 Table 146. Beijing Joinn Biologics Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
 Table 147. Beijing Joinn Biologics Co., Ltd. Recent Development
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Biomacromolecule CDMO Picture
 Figure 2. Global Biomacromolecule CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Biomacromolecule CDMO Market Share by Type: 2024 VS 2031
 Figure 4. Biologics CDMO Features
 Figure 5. Viral Vaccine Production CDMO Features
 Figure 6. Analyze and Test CDMOs Features
 Figure 7. Others Features
 Figure 8. Global Biomacromolecule CDMO Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Biomacromolecule CDMO Market Share by Application: 2024 VS 2031
 Figure 10. Drug Development Case Studies
 Figure 11. Vaccine Production Case Studies
 Figure 12. Technology Transfer Case Studies
 Figure 13. Others Case Studies
 Figure 14. Biomacromolecule CDMO Report Years Considered
 Figure 15. Global Biomacromolecule CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Biomacromolecule CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Biomacromolecule CDMO Market Share by Region: 2024 VS 2031
 Figure 18. Global Biomacromolecule CDMO Market Share by Players in 2024
 Figure 19. Global Top Biomacromolecule CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomacromolecule CDMO as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Biomacromolecule CDMO Revenue in 2024
 Figure 21. North America Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Biomacromolecule CDMO Market Share by Country (2020-2031)
 Figure 23. United States Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Biomacromolecule CDMO Market Share by Country (2020-2031)
 Figure 27. Germany Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Biomacromolecule CDMO Market Share by Region (2020-2031)
 Figure 35. China Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Biomacromolecule CDMO Market Share by Country (2020-2031)
 Figure 43. Mexico Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Biomacromolecule CDMO Market Share by Country (2020-2031)
 Figure 47. Turkey Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Lonza Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
 Figure 51. Wuxi Biologics (Cayman) Inc. Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
 Figure 52. Catalent Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
 Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
 Figure 54. Samsung Biologics Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
 Figure 55. Rentschler Biopharma Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
 Figure 56. Baxter Biopharma Solutions Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
 Figure 57. Merck BioReliance Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
 Figure 58. Cytovance Biologics Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
 Figure 59. AGC Biologics Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
 Figure 60. Abzena Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
 Figure 61. Emergent BioSolutions Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
 Figure 62. ProBioGen Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
 Figure 63. Goodwin Biotechnology Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
 Figure 64. KBI Biopharma Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
 Figure 65. Asymchem Laboratories (Tianjin) Co., Ltd. Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
 Figure 66. Shanghai Chempartner Lifescience Co., Ltd. Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
 Figure 67. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
 Figure 68. Genscript Biotech Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
 Figure 69. Beijing Joinn Biologics Co., Ltd. Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Large Molecule Drug Substance CDMO Market Research Report 2024
Global Biological Drug CDMO Market Research Report 2024
Small Molecule Drug CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical CDMO Market Research Report 2025
Global Chemical CDMO Market Research Report 2024
Pharmaceutical CMO and CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Small Molecules CDMO Services Market Research Report 2024
Global Biopharmaceutical CDMO Market Research Report 2025
Global Chemical Drug CDMO Market Research Report 2024
Global Biopharmaceutical CDMO Service Market Research Report 2024
Global Biopharmaceutical and Bio CDMO Market Research Report 2024
Global Cellular and Gene Therapy CDMO Market Research Report 2025
Global Biologics CDMO Services Market Research Report 2024
Pharmaceutical CDMO Pharmaceutical Contract Development and Manufacturing Organization Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oligonucleotide CDMO Market Research Report 2025
Global Pharmaceutical Contract Development and Manufacturing Organization Market Research Report 2025
Global Cell and Gene Therapy CDMO Services Market Research Report 2024
Global Viral Vector Manufacturing CDMO Services Market Research Report 2024
Global Small Molecule Drug CDMO Services Market Research Report 2024
Biologics CDMO Market

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions